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p120-catenin prevents multinucleation through
control of MKLP1-dependent RhoA activity
during cytokinesis
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Spatiotemporal activation of RhoA and actomyosin contraction underpins cellular adhesion
and division. Loss of cell–cell adhesion and chromosomal instability are cardinal events that
drive tumour progression. Here, we show that p120-catenin (p120) not only controls cell–cell
adhesion, but also acts as a critical regulator of cytokinesis. We ﬁnd that p120 regulates
actomyosin contractility through concomitant binding to RhoA and the centralspindlin
component MKLP1, independent of cadherin association. In anaphase, p120 is enriched at the
cleavage furrow where it binds MKLP1 to spatially control RhoA GTPase cycling. Binding of
p120 to MKLP1 during cytokinesis depends on the N-terminal coiled-coil domain of p120
isoform 1A. Importantly, clinical data show that loss of p120 expression is a common event in
breast cancer that strongly correlates with multinucleation and adverse patient survival.
In summary, our study identiﬁes p120 loss as a driver event of chromosomal instability in
cancer.
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T
umour cells display chromosomal alterations including loss
and gain of complete chromosomes termed aneuploidy1,2.
It is thought that chromosomal instability (CIN) facilitates
tumour plasticity and adaptation to changing environments
through Darwinian selection processes. A number of mechanisms
contribute to CIN including defects in the DNA damage
response, mitotic checkpoints, and cytokinesis. Formation of
malignant cells from binucleated cells is caused by the inheritance
of extra centrosomes, which induces chromosome segregation
errors during subsequent cell divisions1,3. Additional mechanisms
include non-genetic pathways like steric hindrance of
furrow ingression by carcinogens, or cell-in-cell structures
derived through a process termed entosis4. Moreover, genetic
alterations or loss of tumour suppressors can induce cytokinesis
defects and subsequently drive malignant transformation5,6.
Cytokinesis is intricately balanced through spatiotemporal
recruitment and activation of the proteins that form the
actomyosin contractile ring and drive cleavage furrow
ingression7. Centralspindlin, a tetrameric complex composed of
MgcRacGAP and the motor protein MKLP1 (KIF23), localizes to
the central spindle where it regulates balanced actomysosin
contractility during cytokinesis8–10. Recruitment of the RhoGEF
Ect2 to the centralspindlin complex drives local activation of the
small GTPase RhoA, which controls actomyosin contractility and
subsequent furrow ingression11–13. Rapid RhoA GTPase cycling
depends on the presence of positive and negative regulators and
limits lateral diffusion to maintain a restricted active Rho zone
essential for proper cytokinesis14–16.
Loss of cell–cell adhesion is commonly observed in human
cancer upon inactivation of the Adherens Junction (AJ)
components E-cadherin or p120-catenin17–22. Previously, we
demonstrated that mammary-speciﬁc inactivation of E-cadherin
causes the development and progression of invasive lobular breast
carcinoma (ILC)23,24. Cortical stabilization of E-cadherin
depends on binding of p120-catenin to the intracellular
juxtamembrane domain25,26. Although conditional ablation of
p120 causes formation of metastatic breast carcinoma in mice, it
does not lead to ILC but instead induces the formation of
metastatic high-grade ductal-type carcinoma22. These ﬁndings
demonstrated that loss of p120 expression has differential
functional consequences during tumour initiation and
progression that may occur independently of cell–cell adhesion.
Here we show that loss of p120 is causal to the formation of
multinucleated and chromosomally unstable tumour cells in
mouse and human cancer models. Our data reveal that p120 is
enriched at the equatorial cortex during cytokinesis where it
regulates the spatiotemporal activity of RhoA. In addition,
we show that p120 modulates RhoA GTPase cycling through
isoform-speciﬁc binding to MKLP1. Altogether, our data reveal
an unprecedented function for p120 in the regulation of
cytokinesis and provide evidence that loss of p120 supports
tumour progression through loss of cell–cell adhesion and
induction of CIN.
Results
Loss of p120 induces multinucleation and contributes to CIN.
Previous work in our lab has shown that loss of the AJ through
somatic inactivation of either E-cadherin or p120 in the context
of p53 inactivation is causal to the development of metastatic
mammary carcinomas22–24. However, while loss of E-cadherin
and p53 in WAPcre;Cdh1F/F;Trp53F/F female mice induced the
formation of mouse ILC (mILC), homozygous dual inactivation
of p120 and p53 (WAPcre;Ctnnd1F/F;Trp53F/F) induced the
formation of high-grade invasive ductal-type carcinoma
(Fig. 1a). Interestingly, we observed a high incidence of
multinucleated tumour cells and overall severe nuclear atypia in
p120-deﬁcient mammary carcinomas, whereas E-cadherin and
p53-deﬁcient tumours did not show overt nuclear abnormalities
(Fig. 1a). To further examine this we made use of mammary
carcinoma cell lines derived from our mouse models and
observed a high frequency of bi- and multinucleation in PMC-1
cells (Ctnnd1D/D;Trp53D/D) compared with mILC-1 (Cdh1D/D;
Trp53D/D) and Trp53D/D-7 cells (Fig. 1b,c). We next visualized
chromosomal content using multicolour combined binary ratio
(COBRA)-FISH and observed that virtually all PMC-1 cells
showed a numerical increase of chromosomal content (ranging
from 4N to 8N), whereas most p120-proﬁcient Trp53D/D-7
and mILC-1 cell lines displayed a near diploid content
(Supplementary Fig. 1a; Supplementary Table 1). To establish
causality we used a doxycyclin (dox)-inducible shRNA expression
vector to silence p120 (p120-iKD; Supplementary Fig. 1b) and
observed a robust increase in bi- and multinucleation in cell lines
of different origin (Fig. 1d,e). The frequency of bi- and
multinucleation in dox-treated p120-iKD cells accumulated up
to three passages suggesting a continuous process and/or a
selective advantage for the multinucleated state (Fig. 1e).
Multinucleated cells are chromosomally unstable due to the
inheritance of extra centrosomes that can cause chromosome
segregation defects during subsequent cell divisions3. Indeed, we
observed a signiﬁcant increase in centrosome numbers in PMC-1
and dox-treated p120-iKD cell lines and detected an increase of
mononucleated cells expressing more than two centrosomes
(Fig. 1f), indicating that these cells were derived from bi- or
multinucleated cells but reverted to a mononuclear state.
Altogether, our results show that loss of p120 is causal to
multinucleation and contributes to CIN in cancer cells.
p120 loss induces multinucleation independent of cadherins.
Because multinucleation was increased in p120-null mammary
carcinomas compared with E-cadherin-deﬁcient tumours, it
suggested that the induction of multinucleation upon p120 loss
occurs independently of its role at the AJ and/or p53 inactivation.
To substantiate the AJ-independent option we depleted p120
in mILC-1 cells, which are deﬁcient for classical cadherins
(Supplementary Fig. 1b) and observed an accumulation of bi- and
multinucleated cells (Fig. 2a). Moreover, we reconstituted dox-
treated U2OS p120-iKD cells with either full-length (FL) p120-1A
or the p120-1A K410M mutant that contains a substitution at
lysine 401 that disrupts binding to classical cadherins27 (Fig. 2b;
Supplementary Fig. 1c). In line with our hypothesis, we observed
that p120-1A K401M fully rescued the formation of bi- and
multinucleated cells upon p120 loss (Fig. 2c), conﬁrming that loss
of p120 induces multinucleation through a process that is
independent of cadherin association.
Loss of p120 induces cytokinesis defects. Continuous defects
during cytokinesis and/or abscission may represent the
mechanism underlying the induction of multinucleation in p120-
deﬁcient cells. To investigate this we quantiﬁed the timing of
mitosis in PMC-1 cells and p120-iKD cell lines. We did not detect
defects during early mitosis (pro-metaphase and metaphase) in
PMC-1 and Trp53D/D-7 p120-iKD, although the length of the
early stages of mitosis in U2OS p120-iKD was slightly increased
(Fig. 3a). However, the duration of late mitosis and cytokinesis
(anaphase and telophase) was signiﬁcantly increased in PMC-1
and both p120-iKD cell lines (Fig. 3b). In addition, we quantiﬁed
the frequency of lagging chromosomes in U2OS p120-iKD cells
and did not observe an increase after one passage on dox ( dox:
10/34; þ dox: 6/23; P¼ 0.428) indicating that the induction of
CIN through loss of p120 is not caused by early chromosome
segregation errors. However, we observed severe membrane
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Figure 1 | Loss of p120 induces multinucleation and chromosomal instability. (a) Mammary-speciﬁc conditional female mice mutant for p120 and
p53 (WAPcre;Ctnnd1F/F;Trp53F/F), E-cadherin and p53 (WAPcre;Cdh1F/F;Trp53F/F) or p53 alone (WAPcre;Trp53F/F) were stained for p120. Note the overt
multinucleation in the p120 knockout mammary carcinoma cells (arrow) and the prominent inﬂux of p120 expressing immune cells (macrophages; arrow
head). Tissue architecture and nuclear morphology were visualized by H&E stainings. Scale bar, 50mm. (b) Immunoﬂuorescence (IF) imaging of cell lines
(Trp53D/D-7, mILC-1 and PMC-1) derived from the corresponding tumours shown in a. Scale bar, 10 mm. (c) Quantiﬁcation of bi- and multinucleation in the
cell lines shown in b. Statistical signiﬁcance was determined using the w2-test. *Po0.05/zPo0.05 (binucleation and multinucleation, respectively).
(d) Control (-dox) and dox-treated (þ dox) mouse and human cancer cell lines transduced with an inducible p120KD were stained for p120 and Lamin A/
C. Scale bar, 10mm. (e) Quantiﬁcation of bi- and multinucleation of the p120-iKD cell lines shown in d over three consecutive passages in the absence or
presence of dox. At least 200 control and dox-treated cells were analysed every passage. (f) Quantiﬁcation of centrosome numbers in interphase PMC-1,
Trp53D/D-7 p120-iKD and U2OS p120-iKD cells. Centrosome numbers were determined by IF staining for g-tubulin. Statistical signiﬁcance in c,e and f was
determined using the w2-test. *Po0.05/zPo0.05 (binucleation and multinucleation respectively). NS, not signiﬁcant.
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deformations speciﬁcally during anaphase in PMC-1 and
p120-iKD cells, ultimately resulting in cytokinesis failure and the
formation of a binucleated cell (Fig. 3c). High-magniﬁcation
time-lapse imaging showed rapid and prolonged membrane
oscillations starting at the onset of anaphase that suggested
aberrations in actomyosin contraction (Fig. 3d; Supplementary
Movies 1 and 2). Together, our data show that loss of
p120 induces continuous cytokinesis defects characterized by
membrane oscillations that ultimately lead to the generation of
chromosomally unstable multinucleated cancer cells (Fig. 3e).
p120 controls RhoA activity during cytokinesis. Formation of
the contractile ring and subsequent cleavage furrow ingression
during cytokinesis depends on local accumulation and rapid
GTPase cycling of RhoA at the equatorial cortex14,15,28.
Interestingly, while p120 was cortically localized during
anaphase and telophase, we observed distinct enrichment of
p120 at the equatorial cortex and the midbody that overlapped
with accumulation of RhoA (Fig. 4a; Supplementary Fig. 2a/b).
On the basis of this and the ﬁnding that p120 has been suggested
to inhibit Rho GTP loading29, we hypothesized that loss of p120
could result in aberrant RhoA activity during furrow ingression,
analogous to the phenotype observed upon loss of RhoGAP
function during cytokinesis15,16. In contrast to the highly focused
RhoA localization at the equatorial cortex during anaphase in
control U2OS p120-iKD cells, we observed that RhoA expression
was aberrantly localized to distinct membrane protrusions in dox-
treated U2OS p120-iKD cells (Fig. 4b). To assess RhoA activity
during cytokinesis, we used the Rho-speciﬁc RaichuEV FRET
probe30. In contrast to control U2OS p120-iKD cells, we detected
oscillations of active RhoA during cytokinesis (t¼ 5 and t¼ 10)
in dox-treated U2OS p120-iKD cells resulting in non-focused
RhoA activity (t¼ 20 and t¼ 25), which induced cytokinesis
failure and binucleation (Fig. 4c; Supplementary Movies 3 and 4).
In addition, we observed similar aberrations in RhoA activity in
PMC-1 cells and Trp53D/D-7 p120-iKD cells (Supplementary
Fig. 3a,b). In agreement with the mislocalized activity of RhoA,
we detected aberrant localization of phosphorylated MLC2 during
cytokinesis in p120-deﬁcient cells (Supplementary Fig. 3c)
accompanied by rapid oscillations of F-actin accumulation at
sites other than the cleavage furrow (Supplementary Fig. 3d;
Supplementary Movies 5 and 6).
A small lysine-rich region in the Armadillo (ARM) domains of
p120 (residues 622–628) controls the inhibition of RhoA
activity29. To test whether p120 regulates cytokinesis through
modulation of RhoA activity, we reconstituted dox-treated
U2OS p120-iKD with a p120 mutant lacking this region
(p120-1AD[622–628]). While removal of the lysine-rich region
did not induce blebbing to the extent of p120 depletion, we
observed that reconstitution with p120-1AD[622–628] did not
rescue multinucleation, which shows that this p120 region is
crucial for control of RhoA activity at the equatorial cortex during
cytokinesis (Fig. 4d). While p120-1A FL and p120-1A K401M
co-localized with RhoA at the equatorial cortex (Fig. 4e;
Supplementary Fig. 3e), p120-1AD[622–628] did not position to
the equatorial cortex but instead was exclusively localized to the
cytosol (Fig. 4e). Altogether, these data show that proper
cytokinesis depends on local modulation of RhoA-dependent
actomyosin contraction by p120 at the equatorial cortex.
As a result, p120 loss leads to non-focused RhoA activity
during anaphase, which is causal to cytokinesis failure and
multinucleation.
Binding of p120 to MKLP1 controls balanced RhoA activity.
To unravel the mechanism that controls p120-dependent
spatiotemporal regulation of RhoA activity during cytokinesis,
we initially performed p120 immunoprecipitation and subsequent
mass spectrometry on mILC-1 lysates to enrich for cadherin-
independent binding partners (Supplementary Fig. 4a). Interest-
ingly, we identiﬁed several established cytokinesis-related molecules
(Supplementary Dataset 1). Of these, the strongest interaction was
found between p120 and the centralspindlin component mitotic
kinesin-like protein 1 (MKLP1; mascot score: 697). Cen-
tralspindlin is a tetrameric complex composed of MgcRacGAP
and MKLP1 that accumulates at the spindle midzone during
anaphase and functions as an essential regulator of cytokinesis
through recruitment of the RhoGEF Ect2 (refs 11,12,31).
Immunoﬂuorescence microscopy conﬁrmed co-localization of
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p120, RhoA and MKLP1 at the equatorial cortex during anaphase
and telophase (Fig. 5a). To study the functional relevance of the
interaction between p120, RhoA and MKLP1, we depleted
MKLP1 by RNAi and induced cell cycle arrest to avoid early
cytokinesis defects. Upon release we observed an impairment of
cleavage furrow formation and ingression as described before11
(Fig. 5b). Depletion of MKLP1 abolished accumulation of RhoA
speciﬁcally at the equatorial cortex leading to a broad primitive
cleavage furrow (Fig. 5b). In addition, MKLP1-depleted cells
showed an overall decrease in p120 expression at the equatorial
cortex, suggesting that localization of p120 to this region depends
on the presence of RhoA. Supporting this is our ﬁnding that our
mass spectrometry data revealed RhoA as a low-hit p120
interactor (Supplementary Data 1), a ﬁnding we have
conﬁrmed by co-immunoprecipitation of endogenous p120 and
RhoA using western blotting (Supplementary Fig. 4b). We
therefore hypothesized that, although p120 is a global inhibitor
of RhoA, the association between p120 and MKLP1 could provide
the spatial cue that controls RhoA activity at the equatorial cortex
during cytokinesis. To test this, we mapped the MKLP1-binding
region in p120 by co-expressing GFP-MKLP1 with the naturally
occurring p120 isoforms 1A, 3A, 4A, or a truncation mutant
lacking all ARM domains (p120DARM) (Fig. 5c). Interestingly,
only p120-1A and p120DARM precipitated with GFP-MKLP1,
indicating that binding occurs through the N-terminal domain of
p120, which includes the coiled-coil (CC) domain (Fig. 5d). To
determine the signiﬁcance of this interaction, we reconstituted
dox-treated U2OS p120-iKD with either FL p120-1A, or
N-terminal truncation mutants lacking the complete regulatory
domain (p120-1AD[1–346]), or a CC truncation mutant (p120-
1AD[1–27]; Supplementary Fig. 1c). Although the extent of
aberrant actomyosin contraction was not as severe as in the p120
depleted cells, we observed that reconstitution with either
p120-1AD[1–346] or p120-1AD[1–27] was not sufﬁcient to
rescue the bi- and multinucleation (Fig. 5e). Moreover, we
observed that cells reconstituted with these truncation mutants
displayed a broadened RhoA gradient during cytokinesis that was
characterized by a lack of co-localization with p120 at the distal
sides of the RhoA zone (Fig. 5f). Classical Rho GDI molecules act
as inhibitors that mostly interact with Rho GTPases to prevent
nucleotide exchange. Further, they can relocate Rho proteins
from the membranes to the cytosol to prevent activation at
membranes (reviewed in ref. 32). Although it is clear that p120
can control RhoA activity29,33–35, it is not a classical RhoGDI.
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Figure 3 | Loss of p120 induces cytokinesis defects. (a,b) Quantiﬁcations of the length of (a) early mitosis (pro-metaphase and metaphase) and (b) late
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expressing control and dox-treated U2OS p120-iKD. Shown are  100 images. Arrowheads depict severe membrane deformation in dox-treated anaphase
cells leading to cytokinesis failure. Scale bar, 10mm. (e) Loss of p120 induces binucleation through cytokinesis defects during anaphase. During subsequent
cell divisions, this can give rise to chromosomal instability and aneuploidy in cancer cells due to the presence of extra centrosomes.
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Alternatively, p120 could therefore also serve to recruit or activate
factors that directly inhibit RhoA activity. On the basis of
our mass spectrometry results (Supplementary Data 1) we also
identiﬁed ARHGAP11A (MP-GAP) and Anillin as p120
interaction partners. Indeed, we could precipitate p120-1A with
either GFP-tagged MP-GAP or GFP-tagged Anillin from cell
lysates (Supplementary Fig. 4c). Anillin is a scaffold protein that
links RhoA to the actin machinery during cytokinesis36. Recent
ﬁndings demonstrated that MP-GAP is a key GAP targeting
RhoA activation during cytokinesis16 and showed that MP-GAP
loss leads to a cytokinesis defect similar to p120 loss. We therefore
focussed on MP-GAP and conﬁrmed the observation that
exogenous MP-GAP localized to the site of furrow ingression
during anaphase (Supplementary Fig. 4d). This ﬁnding further
underlines the signiﬁcance of RhoA antagonists such as p120 and
MP-GAP as modulators of rapid RhoA GTPase cycling at the
equatorial cortex. During telophase, MP-GAP localized to the
central spindle, speciﬁcally juxtaposed to the sites of phospho-
MLC2 expression (Supplementary Fig. 4d). To visualize inactive
RhoA, we employed phosphorylation of Serine 188 on RhoA
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mean±s.d. *Po0.05/zPo0.05 (binucleation and multinucleation, respectively). (e) IF for p120 and RhoA in dox-treated U2OS p120-IKD cells
reconstituted with FL p120-1A or p120-1AD[622–628]. Note the absence of co-localization of RhoA and p120 in p120-1AD[622–628]-expressing cells
(arrowhead) compared with cells reconstituted with p120-A FL (arrow). Scale bar, 10mm.
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(phospho-RhoA S188) as a surrogate readout, because this is an
important event in the negative regulation of RhoA by protecting
RhoA from degradation and inhibiting Rho-mediated stress ﬁbre
formation37–39. In anaphase, we found phospho-RhoA S188
localized to the plus ends of the microtubule spindle midzone,
suggesting active translocation of phospho-RhoA S188 to the site
of furrow ingression (Supplementary Fig. 4e). Indeed, this
assumption was substantiated by the localization of phospho-
RhoA S188 during telophase. Whereas the majority of total RhoA
co-localized with p120 at the cell cortex, we observed only
minimal phospho-RhoA expression at this site. Interestingly,
most phospho-RhoA S188 expression appeared mutually
exclusive to cortical RhoA (Supplementary Fig. 4e). These data
suggest that during telophase, a pool of inactive RhoA is localized
proximal to the sites of RhoA activation at the midbody, and as
such might enable rapid ﬂuxing of Rho activity; a process that is
dependent on the presence of both positive and negative
regulators near the equatorial cortex during cytokinesis. In this
setting, p120 controls dominant suppression of actomyosin
contraction and the formation of a balanced RhoA gradient
through interaction with MKLP1 and the mitotic RhoGAP
MP-GAP during late mitosis (Supplementary Fig. 5).
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NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13874 ARTICLE
NATURE COMMUNICATIONS | 7:13874 | DOI: 10.1038/ncomms13874 | www.nature.com/naturecommunications 7
Loss of p120 correlates with decreased patient survival. On
the basis of our ﬁndings we examined breast cancer samples to
correlate p120 loss with nuclear atypia and multinucleation and
observed pronounced multinucleation in invasive ductal carci-
noma (IDC) samples that displayed focal loss of p120 expression
(Fig. 6a). In contrast, tumours expressing p120 such as ductal
carcinoma in situ (DCIS) and ILC, did not display obvious
nuclear abnormalities (Fig. 6a). Because mutation or promoter
methylation of p120 is uncommon in cancer22, we determined
the correlation between allelic CTNND1 loss and p120 expression
in a cohort of 1,977 invasive breast tumours. Interestingly,
heterozygous loss was a relatively frequent event (110/1,977) that
correlated with decreased mRNA expression (Fig. 6b and
Supplementary Fig. 6a,b). We next analysed the corresponding
samples by immunohistochemistry and observed signiﬁcant
enrichment for loss of p120 expression, indicating homozygous
CTNND1 inactivation (Fig. 6c,d). Importantly, we observed
pronounced multinucleation and nuclear atypia in these p120-
deﬁcient tumours (Fig. 6e). Moreover, we detected a signiﬁcant
decrease (P¼ 0.0064) in disease-speciﬁc survival in patients
displaying heterozygous loss compared to patients with a neutral
haplotype (Fig. 6f; Supplementary Fig. 6c,d). Altogether, these
clinical data indicate that a high-grade and multinuclear
phenotype correlates with p120-deﬁciency in breast cancer.
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Figure 6 | Heterozygous CTNND1 loss correlates with loss of expression and decreased patient survival. (a) Immunohistochemistry (IHC) showing
p120 and LaminA/C expression in human ductal carcinoma in situ (DCIS), invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Scale bar,
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CTNND1 (blue; n¼ 109). Statistical signiﬁcance was determined using the log-rank test. Censored events are shown as dots and depicted between
parentheses.
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Furthermore, our data are in agreement with the fact that p120 is
not haplo-insufﬁcient in tumour suppression, and suggest that
heterozygous genomic inactivation predisposes to complete loss
of p120 expression and subsequent adverse survival of cancer
patients.
Discussion
Cleavage furrow formation and ingression during cytokinesis
depends on a balanced gradient of localized RhoA activity and
subsequent actomyosin contractility14,15,40. Although the exact
underlying mechanisms remain unclear, data from several labs
including ours, support the notion that p120 can antagonize
RhoA activity29,33–35. Regardless of whether p120 can directly
modulate RhoA activity or impinges on RhoA activation
indirectly through antagonizing molecules, our data clearly
demonstrate that p120 is necessary to correctly position active
RhoA and subsequent actomyosin contraction during cytokinesis.
Due to its control over RhoA and by interacting with MKLP1 and
MP-GAP, we envision that p120 might modulate rapid GTPase
cycling by simultaneous binding to RhoA and the RhoGAP
MP-GAP, whereas the interaction between p120 and MKLP1
provides the spatial signal that anchors RhoA cycling at the
equatorial cortex during cytokinesis. Consistent with this
hypothesis, we show that expression of the RhoA-binding
mutant p120-1AD[622–628] was not sufﬁcient to rescue the
cytokinesis defects upon loss of p120. Interestingly, p120-
1AD[622–628] was predominantly localized to the cytosol,
suggesting that the association with RhoA promotes cortical
positioning of p120 during mitosis and cytokinesis. In addition,
reconstitutions with the N-terminal p120-1A truncation mutants
p120-1AD[1–27] or p120-1AD[1–346] were not able to rescue the
cytokinesis defects, although they still contained the domain that
is responsible for RhoA inhibition. Cells expressing these mutants
typically displayed a broadened or disturbed RhoA zone during
cytokinesis, which is consistent with the notion that MKLP1
provides the spatial signal to ensure p120-dependent focused
equatorial RhoA GTPase cycling. It has been proposed that MP-
GAP may dominantly suppress lateral RhoA activation during
cytokinesis16. Given the phenotypical, quantitive and
spatiotemporal similarity in cytokinesis failure when depleting
either p120 or MP-GAP, we think that regulation of p120-
dependent RhoA inhibition may be controlled by
MP-GAP. Because p120 depletion results in late cytokinesis
failure and the fact that p120 also complexes with Anillin,
we propose that p120 fulﬁls a scaffolding function between the
actomyosin contractile ring and the central spindle by binding to
MKLP1. Our results clearly indicate that p120 controls RhoA
inactivation during cytokinesis, either through direct RhoA
inhibition by unknown mechanisms, or by binding to
MP-GAP. In doing so, p120 plays a decisive regulatory function
by controlling formation of a balanced RhoA-GTP gradient by
limiting the lateral diffusion of actomyosin contraction. In
addition, the binding to MKLP1 suggests that p120 also might
mediate spatial RhoA activation by Ect2, which is recruited to
centralspindlin by MgcRacGAP during anaphase.
Our current data provide a rationale for the previous
observation that p120-null keratinocytes displayed a high
frequency of mitotic alterations41. We furthermore show that
the function of p120 during cytokinesis is speciﬁc for p120
isoform 1A and is not restricted to the epithelial lineage.
Moreover, p120 controls RhoA activity at the equatorial cortex
independent of binding to classical cadherins, suggesting that
different pools reside at speciﬁc locations to control designated
cellular processes. Our data show that p120 is a general RhoA
inhibitor at the cell membrane, but its association with key
cytokinesis players renders it essential for local Rho inhibition
during anaphase and telophase. For the regulation of actomyosin
contraction during late mitosis, we envisage that cell-cycle-
speciﬁc kinases might trigger post-translational modiﬁcations of
the p120 N-terminus to regulate p120 spatio-temporally. The
exact mechanisms and the kinases involved should be the centre
of future research.
It has been become evident that p53 is essential in maintaining
the diploid state by inducing a G1 arrest and/or apoptosis
in binucleated tetraploid cells42–44. Recent data indicated that
binucleated cells derived through chemically induced cytokinesis
failure induced Hippo-dependent stabilization of p53 through
inhibition of the E3 ligase MDM2 by LATS2 (ref. 45). These
results probably explain the high penetrance of binucleation upon
loss of p120, because we used conditional mouse models and cell
lines that were either p53-null, p53 mutant, or overexpressed
MDM2 (U2OS46). Interestingly, in human breast cancer loss of
p120 is mainly observed in focal areas within the tumour22,47,
suggesting that loss of p120 expression is a late event in tumour
progression and is preceded by a ﬁrst hit (for example,
inactivation of p53). Supporting this are in vivo data from our
lab and others that inactivation of p120 in the mammary gland is
only tolerated in the context of p53 deﬁciency22,48. In contrast to
the mammary gland, sole inactivation of p120 in the skin or the
gastro-intestinal tract appears sufﬁcient to induce hyper-
proliferation and tumour formation49–51. Conditional p120 loss
in keratinocytes was linked to mitotic defects and cancer
development41,50, but it remains unclear whether p53
inactivation needs to precede p120 inactivation to allow the
formation of multinucleated tumour cells in these organ types.
In conclusion, we provide an unprecedented and crucial
function for p120 in regulation of cytokinesis, which is
independent of its established role in cadherin-based cell–cell
adhesion. Our data show that p120 plays a key regulatory role in
maintaining a balanced and focused gradient of active RhoA
through interactions with MKLP1, MP-GAP and Anillin during
cytokinesis. Loss of p120 expression, a common feature of
invasive cancers, therefore not only destabilizes cadherin-
dependent cell–cell adhesion, but also induces multinucleation
and CIN by introducing RhoA-dependent cytokinesis defects.
Methods
Origin of animal models and cell lines. Generation of all animal models
and mouse mammary cell lines described in this study have been previously
reported22–24,35. U2OS, T47D and HeLa cells were obtained from ATCC (#HTB-
96, #HTB-133 and #CCL-2, respectively). All cell lines were cultured in DMEM/
F12 supplemented with 6% tetracyclin-free FCS (#SH3007103; HyClone), 2mM
glutamine (#BE17-605E; Lonza), 100Uml 1 penicillin and 10mgml 1
streptomycin. For mouse cell lines the culture medium was additionally
supplemented with 5ng ml 1 EGF and 5 mg ml 1 insulin (#I9278; Sigma). For
induction of shRNA expression cells were incubated with 1 mg ml 1 doxycyclin
for 4 days. For synchronization, U2OS cells were incubated with thymidine
(2.5mM in culture medium) for 20 h to arrest cells in S-phase. Afterwards, cells
were washed multiple times with warm medium, released for 4 h and incubated
with nocodazole (0.83mM in culture medium) for 14 h to arrest cells in pro-
metaphase. Cells were again washed multiple times and ﬁxated at different time
points to enrich for cells in different stages of mitosis and cytokinesis.
Immunohistochemistry. Tissues were isolated and ﬁxed in 4% formalin. Tissues
were dehydrated, cut into 4 mm sections, and stained with hematoxylin and eosin.
For immunohistochemical stainings, ﬁxed sections were rehydrated and incubated
with primary antibodies. The following primary antibodies were used: mouse
anti-p120 (1:500; #610134; BD Biosciences) and rabbit anti-Lamin A (1:200;
#L1293; Sigma). For mouse tissue, endogenous peroxidases were blocked with 3%
H2O2 and biotin-conjugated secondary antibodies were used, followed by incu-
bation with HRP-conjugated streptavidin–biotin complex (DAKO). Substrate was
developed with DAB (DAKO). For human tissue, stainings were performed using a
Ventana BenchMark ULTRA (Roche) and detections were performed using DAB
(DAKO) and NovaRED (#SK-4805; Vector Labs). All scoring was done blinded to
patient characteristics and results of other staining by two independent observers.
Expression of p120 was scored as membranous and/or cytosolic (0 (lowest), 1, 2
and 3(highest)). Expression of p120 was considered lost when the membranous
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score and the cytosolic score r1. Imaging was performed using a Nikon Eclipse
E800 microscope mounted with a Nikon digital camera DXM1200.
Immunoﬂuorescence microscopy. Cells were allowed to adhere to glass cover-
slips overnight and subsequently ﬁxed with 10% trichloroacetic acid (TCA; for
staining of RhoA) or 4% paraformaldehyde. After TCA ﬁxation, cells were washed
three times with 30mM glycine in PBS for 5min (ref. 52), and permeabilized using
0.25% Triton-X100 in PBS for 5min at room temperature. Samples were blocked
with 5% milk in PBS (for RhoA stainings) or 5% BSA in PBS for 1 h. Samples were
incubated with primary antibodies overnight at 4 C. The following primary
antibodies were used: rabbit anti-LaminA/C (1:1,000, #L1293; Sigma) mouse
anti-p120 (1:500; #610134; BD Biosciences), mouse anti-p120-TRITC (1:300;
#610137; BD Biosciences), mouse anti-p120 6H11 (1:500; Santa Cruz
Biotechnology), rat anti-GFP mouse anti-RhoA 26C4 (1:200; sc-418; Santa Cruz
Biotechnology), rat anti-E-cadherin (1:200; #43254; Sigma), rabbit anti-MKLP1/
KIF23 (1:200; sc-857; Santa Cruz Biotechnology), rabbit anti-Ect2 (1:100; #07-1364;
Merck), mouse anti-alpha Tubulin (1:10,000; T5168; Sigma-Aldrich), rat anti-alpha
Tubulin YL1/2 (1:500; MA1-80017; Thermo Scientiﬁc), rat anti-GFP (1:2000;
3H9 Chromotek) and rabbit anti-g Tubulin (1:500; T5192; Sigma-Aldrich).
For detection, samples were incubated with secondary antibodies in blocking
buffer for 1 h at room temperature. The following secondary antibodies
were used: (1:600; Invitrogen): goat anti-mouse Alexa488 (#A11029), goat anti-
rabbit Alexa488 (#A11034), goat anti-mouse Alexa568 (#A11031), goat anti-rabbit
Alexa568 (#A11036), goat anti-rabbit Alexa647 (#A21245) and goat anti-rat
Alexa647 (#A21247). Afterwards, cells were incubated with Alexa633-phalloidin to
visualize F-actin (1:300; #A22284; Life Technologies) or DAPI to stain DNA,
washed and subsequently mounted using ImmunoMount (#9990402; Thermo
Scientiﬁc). Imaging was performed on a LSM700 confocal microscope (Zeiss).
Image processing was performed using ImageJ and Photoshop (Adobe).
Quantiﬁcation of bi/multinucleation and centrosomes. For quantiﬁcation of
binucleation and multinucleation, cells were allowed to adhere to glass coverslips
overnight, ﬁxated with either ice-cold methanol and subsequent stained for
a-Tubulin and DNA (DAPI) for quantiﬁcation of bi- and multinucleation or
ﬁxated with 4% paraformaldehyde and stained for g-Tubulin, a-Tubulin and DNA
(DAPI) for quantiﬁcation of centrosome numbers. Multinucleation was deﬁned as
42 nuclei per cell. For both experiments, random ﬁelds ( 63) were imaged with a
LSM700 (Zeiss) and statistical signiﬁcance was determined using the w2-test.
mRNA expression, copy number and survival data METABRIC. DNA and RNA
from matched pairs were extracted for 1980 tumours53. Copy-number analysis was
performed using the Affymetrix SNP 6.0 platform. These arrays were pre-processed
and normalized using CRMAv2 (ref. 54) method from the aroma.affymetrix R
package. For each of them, allelic-crosstalk calibration, probe sequence effects
normalization, probe-level summarization and PCR fragment length normalization
were performed. Then the array intensities were normalized against a pool of 473
normal samples for those that had no matched normal or against their matched
normal when available. The log-ratios were segmented using the CBS algorithm55
from the DNAcopy Bioconductor package. Finally, copy-number callings into ﬁve
groups (homozygous deletion, heterozygous deletion, neutral copy number, gain
and ampliﬁcation), were made using thresholds based on the variability of each
sample and their proportion of normal contamination. RNA analysis was
performed using Illumina HT-12 v3 platform and analysed with the beadarray
package56. BASH57 algorithm was employed to correct for spatial artefacts.
Bead-level data was summarized and a selection of suitable probes based on their
quality was done using the re-annotation of the Illumina HT-12v3 platform
described in ref. 58. The samples were classiﬁed into the ﬁve breast cancer subtypes
using PAM50 (ref. 59). Kaplan–Meier estimates and log-rank tests were obtained
using the survival R package. Comparison of expression levels and copy-number
states was performed ﬁtting a linear model and then computing simultaneous
testing using Tukey’s method from the multicomp R package60.
COBRA-FISH. For gross analysis of structural variation, COBRA-FISH analysis
was performed as described before (detailed protocol available in reference)61.
Constructs. Cloning of the doxycycline-inducible shRNA constructs directed
against mouse and human p120 and generation of the non-targetable p120 cDNA
expression construct (pLV.CMV.p120.IRES.puro) were previously described22. All
p120 mutants were generated by PCR-directed cloning, using the non-targetable
p120 cDNA in pEGFP-C1 as template. PCR was performed using Phusion DNA
polymerase (#M0530S;NEB) and corresponding primers (Table 1). Amplicons were
phosphorylated with T4 polynucleotide kinase (#M0202L; NEB) and ligated.
Afterwards, all GFP-tagged constructs were ampliﬁed from the vector with primers
containing AscI and NheI sites, digested and ligated in pLV.CMV.IRES.puro. All
constructs were sequence veriﬁed. Constructs used for pulldown experiments (RC-
CMV-p120-1A, -3A, -4A and DARM(1–10)) were a kind gift from P. Anastasiadis
(Mayo Clinic, Jacksonville, FL), and were previously described62. GFP-tagged
MKLP1 in pEGFP-C1 was a kind gift from A. Akhmanova (Utrecht University,
The Netherlands) and GFP-tagged Anillin was obtained from Addgene (pEGFP-
Anillin; #68027). GFP-tagged MP-GAP (ARHGAP11A) was generated by PCR
using Phusion polymerase (Thermo Fischer Scientiﬁc) from a cDNA library
derived from U2OS mRNA (kind gift from Susanne Lens) using the following
primers (50-GCTACTCGAGCTATGTGGGATCAGAGGCTG-30 and 50-TGCAG
GATCCTTACAAATCTACAGGTTTACTTGTTGG-30). The resulting amplicon,
ﬂanked by EcoRI and BamHI sites, was cloned into pEGFP-C1 (Clontech) to
generate GFP-tagged MP-GAP.
Time-lapse imaging. To visualize mitosis and cytokinesis, U2OS cells were
transduced with Baculovirus expressing H2B-mCherry in combination with either
GFP-a-tubulin (kind gifts from M. Hadders and S. Lens, University Medical
Center Utrecht, Utrecht, The Netherlands) or GFP-actin (CellLight; C10582; Life
Technologies). Cells were imaged with a Personal Deltavision (GE Healthcare) in
Leibovitz medium (Gibco) supplemented as described in previous sections. Images
were processed with ImageJ.
FRET microscopy and image processing. The RaichuEV-RhoA biosensor was a
kind gift from Professor M. Matsuda, Kyoto University, Japan. U2OS cells were
transfected with the probe containing the PiggyBac transposon system (Wellcome
Trust Sanger Institute, Hinxton, UK) using Lipofectamine 2,000 Transfection
Reagent (Life Technologies) according to manufacturer’s instructions. Cells were
seeded on 35mm glass-base dishes at a density of 1.5 104 and transfected with
the H2B-mCherry baculovirus overnight to allow visualization of the nucleus.
FRET images were acquired using a Zeiss 710 inverted microscope equipped with
458 nm argon laser and 561 nm DPSS laser through an MBS 458/561 ﬁlter.
Emission light of the biosensor was separated by beam splitters into 462–511 nm
for Turquoise-GL, 521–559 nm for FRET and 602–697 nm for mCherry. Stacked
images of seven sections (0.85 mm distance) were acquired every 5min to capture
FRET information in 3D for up to 24 h. Using Metamorph software, sectioned
images were made into sum stacks and background subtracted before generating a
ratio image (YFP/CFP).
siRNA-mediated MKLP1 depletion. U2OS cells were transfected with siRNAs
(ﬁnal concentration 20mM) directed against MKLP1 (50-CGACAUAACUUACG
ACAAAUU-30) or luciferase (50-CGUACGCGGAAUACUUCGA-30). In short,
siRNAs were mixed with 1.5 ml HiPerfect Transfection Reagent (#301705; Qiagen)
in 100 ml OptiMEM and incubated at room temperature for 30min. The reaction
mixture was added to the cell suspension in a 24-well plate (Costar) containing a
12mm glass coverslip. The next day, cells were incubated with thymidine at a ﬁnal
concentration of 2.5mM for 24 h. Afterwards, cells were released through multiple
washes and ﬁxed B8 h later to obtain cells in anaphase/telophase.
Mass spectrometry. Preparation of samples and mass spectrometry were
performed as previously described35. In summary, protein bands were stained and
visualized using SYPRO Ruby (Invitrogen). Peptides were extracted with 10%
formic acid (BDH) and subjected to LC–tandem MS analysis (1,100 HPLC system;
Agilent Technologies) connected to an LTQ Linear Ion Trap Mass Spectrometer
combined with an Orbitrap (ThermoFisher). The International Protein Index (IPI)
mouse database (http://www.ebi.ac.uk/IPI/) was used as a reference using Mascot
software (version 2.2.0; Matrix Science). Peptides with mascot scores greater than
30 were considered for further analysis.
Table 1 | primers used to clone p120-1A constructs.
Construct Forward primer Reverse primer
p120-1A K401M 50-ATGACTGACGTGCGGAAGC-30 50-CACCTTGTCATTGCGGTAGC-30
p120-1AD[622–628] 50-CCTACAGAGGATCCAGCAAATGATAC-30 50-GGCTCCAAAGCAACTGGC-30
p120-1AD[1–27] 50-CGGGCGCTGGAAGAGG-30 50-GGTGGCGGAATTCGAAGC-30
p120-1AD[1–347] 50-TTAGCAAGCTTGGATAGTTTGCG-30 50-GGTGGCGGAATTCGAAGC-30
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Anti-GFP immunoprecipitations and western blotting. 293T cells plated in a
10 cm culture dish were transfected using XtremeGene9 (#06365809001; Roche)
and 2 mg GFP-MKLP1 and 6 mg of either p120-1A, p120-3A, p120-4A,
p120DARM or empty vector. GFP-Trap anti-GFP beads (#gta-20; Chromotek)
were used to perform the GFP-MKLP1, GFP-Anillin and GFP-MP-GAP
co-immunoprecipitations. Western blotting was performed using the following
primary antibodies: mouse anti-p120 (1:2,000; Clone 98/pp120; Becton Dickinson),
rabbit anti-p120 (1:500; H90/sc-13957; Santa Cruz Biotechnology), rabbit anti-GFP
(1:500; sc-8334, Santa Cruz Biotechnology), mouse anti-RhoA (1:300; 26C4/sc-418;
Santa Cruz Biotechnology) and goat anti-Akt (1:1,000, C-20/sc-1618; Santa Cruz
Biotechnology). Uncropped blots are supplied in Supplementary Fig. 7.
Data availability. All relevant data are available from the authors on request
and/or are included with the manuscript (as ﬁgure source data or Supplementary
Information ﬁles).
References
1. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal
cancers. Nature 386, 623–627 (1997).
2. Storchova, Z. & Kuffer, C. The consequences of tetraploidy and aneuploidy.
J. Cell Sci. 121, 3859–3866 (2008).
3. Ganem, N. J., Godinho, S. A. & Pellman, D. A mechanism linking extra
centrosomes to chromosomal instability. Nature 460, 278–282 (2009).
4. Krajcovic, M. et al. A non-genetic route to aneuploidy in human cancers. Nat.
Cell Biol. 13, 324–330 (2011).
5. Hernando, E. et al. Rb inactivation promotes genomic instability by
uncoupling cell cycle progression from mitotic control. Nature 430, 797–802
(2004).
6. Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis
in mice. Cancer Cell 11, 9–23 (2007).
7. White, E. A. & Glotzer, M. Centralspindlin: at the heart of cytokinesis.
Cytoskeleton (Hoboken) 69, 882–892 (2012).
8. Mishima, M., Kaitna, S. & Glotzer, M. Central spindle assembly and cytokinesis
require a kinesin-like protein/RhoGAP complex with microtubule bundling
activity. Dev. Cell 2, 41–54 (2002).
9. Pavicic-Kaltenbrunner, V., Mishima, M. & Glotzer, M. Cooperative assembly of
CYK-4/MgcRacGAP and ZEN-4/MKLP1 to form the centralspindlin complex.
Mol. Biol. Cell 18, 4992–5003 (2007).
10. Basant, A. et al. Aurora B kinase promotes cytokinesis by inducing
centralspindlin oligomers that associate with the plasma membrane. Dev. Cell
33, 204–215 (2015).
11. Yu¨ce, O., Piekny, A. & Glotzer, M. An ECT2-centralspindlin complex regulates
the localization and function of RhoA. J. Cell Biol. 170, 571–582 (2005).
12. Nishimura, Y. & Yonemura, S. Centralspindlin regulates ECT2 and RhoA
accumulation at the equatorial cortex during cytokinesis. J. Cell Sci. 119,
104–114 (2006).
13. Petronczki, M., Glotzer, M., Kraut, N. & Peters, J.-M. Polo-like kinase 1 triggers
the initiation of cytokinesis in human cells by promoting recruitment of the
RhoGEF Ect2 to the central spindle. Dev. Cell 12, 713–725 (2007).
14. Miller, A. L., Dassow, von, G. & Bement, W. M. Control of the cytokinetic
apparatus by ﬂux of the Rho GTPases. Biochem. Soc. Trans. 36, 378–380 (2008).
15. Miller, A. L. & Bement, W. M. Regulation of cytokinesis by Rho GTPase ﬂux.
Nat. Cell Biol. 11, 71–77 (2009).
16. Zanin, E. et al. A conserved RhoGAP limits M phase contractility and
coordinates with microtubule asters to conﬁne RhoA during cytokinesis. Dev.
Cell 26, 496–510 (2013).
17. Oda, T. et al. E-cadherin gene mutations in human gastric carcinoma cell lines.
Proc. Natl Acad. Sci. USA 91, 1858–1862 (1994).
18. Berx, G. et al. E-cadherin is a tumour/invasion suppressor gene mutated in
human lobular breast cancers. EMBO J. 14, 6107–6115 (1995).
19. Yoshiura, K. et al. Silencing of the E-cadherin invasion-suppressor gene by CpG
methylation in human carcinomas. Proc. Natl Acad. Sci. USA 92, 7416–7419
(1995).
20. Graff, J. et al. E-cadherin expression is silenced by DNA hypermethylation in
human breast and prostate carcinomas. Cancer Res. 55, 5195–5199 (1995).
21. Thoreson, M. A. & Reynolds, A. B. Altered expression of the catenin p120 in
human cancer: implications for tumor progression. Differentiation 70, 583–589
(2002).
22. Schackmann, R. C. J. et al. Loss of p120-catenin induces metastatic progression
of breast cancer by inducing anoikis resistance and augmenting growth factor
receptor signaling. Cancer Res. 73, 4937–4949 (2013).
23. Derksen, P. W. B. et al. Somatic inactivation of E-cadherin and p53 in mice
leads to metastatic lobular mammary carcinoma through induction of anoikis
resistance and angiogenesis. Cancer Cell 10, 437–449 (2006).
24. Derksen, P. W. B. et al. Mammary-speciﬁc inactivation of E-cadherin and p53
impairs functional gland development and leads to pleomorphic invasive
lobular carcinoma in mice. Dis. Models Mech. 4, 347–358 (2011).
25. Davis, M. A., Ireton, R. C. & Reynolds, A. B. A core function for p120-catenin
in cadherin turnover. J. Cell Biol. 163, 525–534 (2003).
26. Nanes, B. A. et al. p120-catenin binding masks an endocytic signal conserved in
classical cadherins. J. Cell Biol. 199, 365–380 (2012).
27. Ishiyama, N. et al. Dynamic and static interactions between p120 catenin
and E-cadherin regulate the stability of cell-cell adhesion. Cell 141, 117–128
(2010).
28. Kishi, K., Sasaki, T., Kuroda, S., Itoh, T. & Takai, Y. Regulation of cytoplasmic
division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange
protein (rho GDI). J. Cell Biol. 120, 1187–1195 (1993).
29. Anastasiadis, P. et al. Inhibition of RhoA by p120 catenin. Nat. Cell Biol. 2,
637–644 (2000).
30. Komatsu, N. et al. Development of an optimized backbone of FRET biosensors
for kinases and GTPases. Mol. Biol. Cell 22, 4647–4656 (2011).
31. Somers, W. G. & Saint, R. A RhoGEF and Rho family GTPase-activating
protein complex links the contractile ring to cortical microtubules at the onset
of cytokinesis. Dev. Cell 4, 29–39 (2003).
32. Garcia-Mata, R., Boulter, E. & Burridge, K. The ‘invisible hand’: regulation
of RHO GTPases by RHOGDIs. Nat. Rev. Mol. Cell Biol. 12, 493–504 (2011).
33. Yanagisawa, M. et al. A p120 catenin isoform switch affects Rho activity,
induces tumor cell invasion, and predicts metastatic disease. J. Biol. Chem. 283,
18344–18354 (2008).
34. Noren, N. K., Liu, B. P., Burridge, K. & Kreft, B. p120 catenin regulates the actin
cytoskeleton via Rho family GTPases. J. Cell Biol. 150, 567–580 (2000).
35. Schackmann, R. C. J. et al. Cytosolic p120-catenin regulates growth of
metastatic lobular carcinoma through Rock1-mediated anoikis resistance.
J. Clin. Invest. 121, 3176–3188 (2011).
36. Piekny, A. J. & Glotzer, M. Anillin is a scaffold protein that links RhoA, actin,
and myosin during cytokinesis. Curr. Biol. 18, 30–36 (2008).
37. Lang, P. et al. Protein kinase A phosphorylation of RhoA mediates the
morphological and functional effects of cyclic AMP in cytotoxic lymphocytes.
EMBO J. 15, 510–519 (1996).
38. Tamma, G. et al. cAMP-induced AQP2 translocation is associated with RhoA
inhibition through RhoA phosphorylation and interaction with RhoGDI. J. Cell
Sci. 116, 1519–1525 (2003).
39. Rolli-Derkinderen, M. et al. Phosphorylation of serine 188 protects RhoA from
ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.
Circ. Res. 96, 1152–1160 (2005).
40. Bement, W. M., Miller, A. L. & Dassow von, G. Rho GTPase activity zones and
transient contractile arrays. Bioessays 28, 983–993 (2006).
41. Perez-Moreno, M., Song, W., Pasolli, H. A., Williams, S. E. & Fuchs, E. Loss of
p120 catenin and links to mitotic alterations, inﬂammation, and skin cancer.
Proc. Natl Acad. Sci. USA 105, 15399–15404 (2008).
42. Andreassen, P. R., Lohez, O. D., Lacroix, F. B. & Margolis, R. L. Tetraploid state
induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol.
Biol. Cell 12, 1315–1328 (2001).
43. Senovilla, L. et al. p53 represses the polyploidization of primary mammary
epithelial cells by activating apoptosis. Cell Cycle 8, 1380–1385 (2009).
44. Kuffer, C., Kuznetsova, A. Y. & Storchova, Z. Abnormal mitosis triggers
p53-dependent cell cycle arrest in human tetraploid cells. Chromosoma 122,
305–318 (2013).
45. Ganem, N. J. et al. Cytokinesis failure triggers hippo tumor suppressor pathway
activation. Cell 158, 833–848 (2014).
46. Flørenes, V. A. et al. MDM2 gene ampliﬁcation and transcript levels in human
sarcomas: relationship to TP53 gene status. J. Natl Cancer Inst. 86, 1297–1302
(1994).
47. Dillon, D., D’Aquila, T., Reynolds, A., Fearon, E. & Rimm, D. The expression of
p120ctn protein in breast cancer is independent of alpha- and beta-catenin and
E-cadherin. Am. J. Pathol. 152, 75–82 (1998).
48. Kurley, S. J. et al. p120-catenin is essential for terminal end bud function and
mammary morphogenesis. Development 139, 1754–1764 (2012).
49. Stairs, D. B. et al. Deletion of p120-catenin results in a tumor
microenvironment with inﬂammation and cancer that establishes it as a tumor
suppressor gene. Cancer Cell 19, 470–483 (2011).
50. Perez-Moreno, M. et al. p120-catenin mediates inﬂammatory responses in the
skin. Cell 124, 631–644 (2006).
51. Smalley-Freed, W. G. et al. p120-catenin is essential for maintenance of barrier
function and intestinal homeostasis in mice. J. Clin. Invest. 120, 1824–1835
(2010).
52. Ratheesh, A. et al. Centralspindlin and a-catenin regulate Rho signalling at the
epithelial zonula adherens. Nat. Cell Biol. 14, 818–828 (2012).
53. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature 486, 346–352 (2012).
54. Bengtsson, H., Wirapati, P. & Speed, T. P. A single-array preprocessing method
for estimating full-resolution raw copy numbers from all Affymetrix
genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics 25,
2149–2156 (2009).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13874 ARTICLE
NATURE COMMUNICATIONS | 7:13874 | DOI: 10.1038/ncomms13874 | www.nature.com/naturecommunications 11
55. Venkatraman, E. S. & Olshen, A. B. A faster circular binary segmentation
algorithm for the analysis of array CGH data. Bioinformatics 23, 657–663
(2007).
56. Dunning, M. J., Smith, M. L., Ritchie, M. E. & Tavare´, S. beadarray: R classes
and methods for Illumina bead-based data. Bioinformatics 23, 2183–2184
(2007).
57. Cairns, J. M., Dunning, M. J., Ritchie, M. E., Russell, R. & Lynch, A. G. BASH:
a tool for managing BeadArray spatial artefacts. Bioinformatics 24, 2921–2922
(2008).
58. Barbosa-Morais, N. L. et al. A re-annotation pipeline for Illumina BeadArrays:
improving the interpretation of gene expression data. Nucleic Acids Res. 38,
e17–e17 (2010).
59. Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic
subtypes. J. Clin. Oncol. 27, 1160–1167 (2009).
60. Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general
parametric models. Biomed. J. 50, 346–363 (2008).
61. Szuhai, K. & Tanke, H. J. COBRA: combined binary ratio labeling of
nucleic-acid probes for multi-color ﬂuorescence in situ hybridization
karyotyping. Nat. Protoc. 1, 264–275 (2006).
62. Yanagisawa, M. et al. A novel interaction between kinesin and p120
modulates p120 localization and function. J. Biol. Chem. 279, 9512–9521 (2004).
Acknowledgements
We thank the Derksen and Lens lab members for critical input. We speciﬁcally thank M.
Hadders and S. Lens for providing the H2B-mCherry expressing baculovirus and U2OS
cDNA library, Q. Liu and A. Ahkmanova for providing pEGFP-C1-MKLP1,
P. Anastasiadis for the p120 isoforms and DARM constructs and K. Green for the
N-terminal p120-1A truncation mutant. M. Vromans, L. Kleij, C. ten Brink and the
Cell Microscopy Center are acknowledged for technical and imaging support. We thank
Albert Heck and The Netherlands Proteomics Centre for help with mass spectrometry
analyses. D.P. is funded by Breast Cancer Now (Grant reference 6151). E.S. and D.P. are
funded by the Francis Crick Institute which receives its core funding from Cancer
Research UK (FC001144), the UK Medical Research Council (FC001144), and the
Wellcome Trust (FC001144). These studies were ﬁnancially supported by grants from the
Netherlands Organization for Scientiﬁc Research (NWO/ZonMW-VIDI 0616.096.318)
and the Dutch Cancer Society (KWF-UU-2011-5230).
Author contributions
R.A.H.v.d.V., J.S.d.G., D.P., R.v.D., D.d.J. and P.W.B.D. conceived and performed the
experiments. K.S., E.S., E.v.d.W., O.M.R., H.R.A., C.C., P.J.v.D. and M.W.H. provided
expertise and feedback. R.A.H.v.d.V. and P.W.B.D. wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: van de Ven, R. A. H. et al. p120-catenin prevents
multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.
Nat. Commun. 7, 13874 doi: 10.1038/ncomms13874 (2016).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2016
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13874
12 NATURE COMMUNICATIONS | 7:13874 | DOI: 10.1038/ncomms13874 | www.nature.com/naturecommunications
Corrigendum: p120-catenin prevents
multinucleation through control of MKLP1-
dependent RhoA activity during cytokinesis
Robert A.H. van de Ven, Jolien S. de Groot, Danielle Park, Robert van Domselaar, Danielle de Jong, Karoly Szuhai,
Elsken van der Wall, Oscar M. Rueda, H. Raza Ali, Carlos Caldas, Paul J. van Diest, Martin W. Hetzer, Erik Sahai
& Patrick W.B. Derksen
Nature Communications 7:13874 doi: 10.1038/ncomms13874 (2016); Published 22 Dec 2016; Updated 6 Sep 2017
The ﬁnancial support for this Article was not fully acknowledged. The Acknowledgements should have included the National Institutes
of Health grants R01GM098749 and National Institutes of Health Transformative Research Award R01NS096786.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in
a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
DOI: 10.1038/ncomms16030 OPEN
NATURE COMMUNICATIONS | 8:16030 |DOI: 10.1038/ncomms16030 |www.nature.com/naturecommunications 1
